Detalhe da pesquisa
1.
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
Cancer
; 130(8): 1234-1245, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127487
2.
Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity.
Cancer Causes Control
; 35(1): 133-151, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599335
3.
Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations.
Gynecol Oncol
; 174: 148-156, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207499
4.
Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
Cancer
; 128(23): 4063-4073, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239009
5.
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 20(5): 636-648, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948273
6.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med
; 375(22): 2154-2164, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717299
7.
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Gynecol Oncol
; 155(1): 39-50, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427143
8.
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Br J Cancer
; 118(8): 1123-1129, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29555990
9.
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
Gynecol Oncol Rep
; 51: 101332, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362364
10.
Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender.
SSM Popul Health
; 24: 101540, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920304
11.
The American Society of Clinical Oncology 2016 annual meeting: A review and summary of selected abstracts.
Gynecol Oncol
; 144(1): e1-e7, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27823770
12.
The American Society of Clinical Oncology 2017 Annual Meeting: A review and summary of selected abstracts.
Gynecol Oncol
; 146(3): 443-448, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693948
13.
Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis.
Adv Radiat Oncol
; 7(1): 100804, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079662
14.
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects.
Cancer Res Commun
; 2(11): 1436-1444, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970052
15.
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers.
J Exp Clin Cancer Res
; 41(1): 232, 2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35883104
16.
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
PLoS One
; 16(6): e0252665, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081738
17.
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.
Am Surg
; 86(10): 1243-1247, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106023
18.
Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
Cancer Res
; 79(10): 2662-2668, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30914430
19.
Trends and outcomes of women with synchronous endometrial and ovarian cancer.
Oncotarget
; 9(47): 28757-28771, 2018 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29983894
20.
Breast cancer following ovarian cancer in BRCA mutation carriers.
JAMA Surg
; 149(12): 1306-13, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25372568